RBRK vs. UTHR
RBRK (Rubrik, Inc.) and UTHR (United Therapeutics Corporation) are both stocks. RBRK operates in Software - Infrastructure (Technology), while UTHR operates in Biotechnology (Healthcare). Over the past year, RBRK returned -26.74% vs 67.18% for UTHR. At a 0.06 correlation, their price movements are largely independent.
Performance
RBRK vs. UTHR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RBRK achieves a -6.21% return, which is significantly lower than UTHR's 11.79% return.
RBRK
- 1D
- -2.29%
- 1M
- 15.06%
- YTD
- -6.21%
- 6M
- -19.49%
- 1Y
- -26.74%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
UTHR
- 1D
- -0.94%
- 1M
- -3.58%
- YTD
- 11.79%
- 6M
- 13.59%
- 1Y
- 67.18%
- 3Y*
- 33.59%
- 5Y*
- 25.53%
- 10Y*
- 17.20%
RBRK vs. UTHR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
RBRK Rubrik, Inc. | -6.21% | 17.01% | 69.33% |
UTHR United Therapeutics Corporation | 11.79% | 38.09% | 48.88% |
Correlation
The correlation between RBRK and UTHR is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.09 |
Correlation (All Time) Calculated using the full available price history since Apr 25, 2024 | 0.06 |
The correlation between RBRK and UTHR shifts across timeframes, from -0.09 (1 year) to 0.06 (all time), reflecting how their relationship changes across market environments.
Fundamentals
RBRK:
$14.61B
UTHR:
$25.71B
RBRK:
-$1.45
UTHR:
$27.00
RBRK:
9.99
UTHR:
8.19
RBRK:
$1.42B
UTHR:
$3.17B
RBRK:
$1.15B
UTHR:
$2.74B
RBRK:
-$275.30M
UTHR:
$1.75B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RBRK vs. UTHR — Risk / Return Rank
RBRK
UTHR
RBRK vs. UTHR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rubrik, Inc. (RBRK) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RBRK | UTHR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.78 | ||
| Sortino ratioReturn per unit of downside risk | -3.02 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.37 | -0.41 |
| Calmar ratioReturn relative to maximum drawdown | -0.48 | 4.13 | -4.61 |
| Martin ratioReturn relative to average drawdown | -0.89 | 10.54 | -11.43 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RBRK | UTHR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.43 | 1.36 | -1.78 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.73 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.49 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.58 | 0.38 | +0.19 |
Drawdowns
RBRK vs. UTHR - Drawdown Comparison
The maximum RBRK drawdown since its inception was -56.08%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for RBRK and UTHR.
Loading charts...
Drawdown Indicators
| RBRK | UTHR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -56.08% | -93.18% | +37.10% |
Max Drawdown (1Y)Largest decline over 1 year | -55.52% | -16.35% | -39.17% |
Max Drawdown (3Y)Largest decline over 3 years | — | -33.00% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -33.00% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -55.56% | — |
Current DrawdownCurrent decline from peak | -28.08% | -8.73% | -19.35% |
Average DrawdownAverage peak-to-trough decline | -18.55% | -35.31% | +16.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.44% | 6.39% | +24.05% |
Volatility
RBRK vs. UTHR - Volatility Comparison
Rubrik, Inc. (RBRK) has a higher volatility of 20.05% compared to United Therapeutics Corporation (UTHR) at 5.15%. This indicates that RBRK's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RBRK | UTHR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.05% | 5.15% | +14.90% |
Volatility (6M)Calculated over the trailing 6-month period | 49.12% | 26.01% | +23.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 63.09% | 49.84% | +13.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 64.32% | 35.13% | +29.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 64.32% | 35.07% | +29.25% |
Dividends
RBRK vs. UTHR - Dividend Comparison
Neither RBRK nor UTHR has paid dividends to shareholders.
Financials
RBRK vs. UTHR - Financials Comparison
This section allows you to compare key financial metrics between Rubrik, Inc. and United Therapeutics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RBRK vs. UTHR - Profitability Comparison
RBRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rubrik, Inc. reported a gross profit of 311.78M and revenue of 387.07M. Therefore, the gross margin over that period was 80.6%.
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.
RBRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rubrik, Inc. reported an operating income of -52.63M and revenue of 387.07M, resulting in an operating margin of -13.6%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.
RBRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rubrik, Inc. reported a net income of -41.85M and revenue of 387.07M, resulting in a net margin of -10.8%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.
Frequently Asked Questions
RBRK and UTHR have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RBRK has higher volatility (20.05%) compared to UTHR (5.15%). In terms of maximum drawdown, RBRK dropped -56.08% vs UTHR's -93.18%.
UTHR currently has the higher Sharpe Ratio (1.36 vs -0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RBRK and UTHR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer